275 related articles for article (PubMed ID: 36941643)
101. Transperineal low-dose rate iridium-192 interstitial brachytherapy in cervical carcinoma stage IIB.
Budrukkar AN; Shrivastava SK; Jalali R; Agarwal JP; Deshpande DD; Nehru RM; Dinshaw KA
Strahlenther Onkol; 2001 Oct; 177(10):517-24. PubMed ID: 11680016
[TBL] [Abstract][Full Text] [Related]
102. Dynamics of High Risk Clinical Target Volume reduction during Brachytherapy and impact on its coverage in patients with inoperable cervical cancer.
Pobijakova M; Scepanovic D; Paluga M; Fekete M; Mardiak J
Neoplasma; 2018 Mar; 65(3):425-430. PubMed ID: 29788726
[TBL] [Abstract][Full Text] [Related]
103. Large volume was associated with increased risk of acute non-hematologic adverse events in the hybrid of intracavitary and interstitial brachytherapy for locally advanced uterine cervical cancer: preliminary results of prospective phase I/II clinical trial.
Murakami N; Watanabe M; Uno T; Sekii S; Tsujino K; Kasamatsu T; Machitori Y; Aoshika T; Kato S; Hirowatari H; Kaneyasu Y; Nakagawa T; Ikushima H; Ando K; Murata M; Yoshida K; Yoshioka H; Murata K; Ohno T; Okonogi N; Saito A; Ichikawa M; Okuda T; Tsuchida K; Sakurai H; Yoshimura R; Yoshioka Y; Yorozu A; Okamoto H; Inaba K; Kato T; Igaki H; Itami J
Jpn J Clin Oncol; 2022 Aug; 52(8):859-868. PubMed ID: 35470390
[TBL] [Abstract][Full Text] [Related]
104. A Prospective Comparison of Computed Tomography with Transrectal Ultrasonography Assistance and Magnetic Resonance Imaging-Based Target-Volume Definition During Image Guided Adaptive Brachytherapy for Cervical Cancers.
Mahantshetty U; Naga Ch P; Khadanga CR; Gudi S; Chopra S; Gurram L; Jamema S; Ghadi Y; Shrivastava S
Int J Radiat Oncol Biol Phys; 2018 Dec; 102(5):1448-1456. PubMed ID: 30146092
[TBL] [Abstract][Full Text] [Related]
105. Correlation between the treated volume, the GTV and the CTV at the time of brachytherapy and the histopathologic findings in 33 patients with operable cervix carcinoma.
Muschitz S; Petrow P; Briot E; Petit C; De Crevoisier R; Duvillard P; Morice P; Haie-Meder C
Radiother Oncol; 2004 Nov; 73(2):187-94. PubMed ID: 15542166
[TBL] [Abstract][Full Text] [Related]
106. Diffusion-weighted MRI in image-guided adaptive brachytherapy: Tumor delineation feasibility study and comparison with GEC-ESTRO guidelines.
Schernberg A; Balleyguier C; Dumas I; Gouy S; Escande A; Bentivegna E; Morice P; Deutsch E; Haie-Meder C; Chargari C
Brachytherapy; 2017; 16(5):956-963. PubMed ID: 28673762
[TBL] [Abstract][Full Text] [Related]
107. Dose-volume parameters and clinical outcome of CT-guided free-hand high-dose-rate interstitial brachytherapy for cervical cancer.
Wang Y; Ye WJ; Du LH; Li AJ; Ren YF; Cao XP
Chin J Cancer; 2012 Dec; 31(12):598-604. PubMed ID: 22640625
[TBL] [Abstract][Full Text] [Related]
108. Characteristics of preplan-based three-dimensional individual template-guided brachytherapy compared to freehand implantation.
Zhang B; Zhang S; Sun L; Wu Y; Yang Y
J Appl Clin Med Phys; 2023 Mar; 24(3):e13840. PubMed ID: 36350283
[TBL] [Abstract][Full Text] [Related]
109. Overall Severe Morbidity After Chemo-Radiation Therapy and Magnetic Resonance Imaging-Guided Adaptive Brachytherapy in Locally Advanced Cervical Cancer: Results From the EMBRACE-I Study.
Vittrup AS; Kirchheiner K; Pötter R; Fokdal LU; Jensen NBK; Spampinato S; Haie-Meder C; Schmid MP; Sturdza AE; Mahantshetty U; Hoskin P; Segedin B; Bruheim K; Rai B; Wiebe E; van der Steen-Banasik E; Cooper R; Van Limbergen E; Sundset M; Pieters BR; Kirisits C; Lindegaard JC; Jürgenliemk-Schulz IM; Nout R; Tanderup K;
Int J Radiat Oncol Biol Phys; 2023 Jul; 116(4):807-824. PubMed ID: 36641039
[TBL] [Abstract][Full Text] [Related]
110. Evaluating outcomes and toxicities for a newly implemented MRI-based brachytherapy program for cervical cancer.
Ross DH; Gomez K; Harmon G; Mysz ML; Shea SM; Goldberg A; Liotta M; Potkul R; Winder A; Lee B; Jackson J; Roeske JC; Small W; Harkenrider MM
Gynecol Oncol; 2024 Apr; 183():33-38. PubMed ID: 38492475
[TBL] [Abstract][Full Text] [Related]
111. Case report: Cervical brachytherapy technique for locally advanced cervical cancer in a patient with complete bicorporeal uterus.
Ding L; Zheng Z; Cao Y; Wang Z; Zhu B; Miao G; Yuan W
Front Oncol; 2024; 14():1361562. PubMed ID: 38903713
[TBL] [Abstract][Full Text] [Related]
112. A randomized trial evaluating a novel hydrogel packing system compared to standard packing during image-guided high-dose rate brachytherapy boost for cervical cancer.
Romano KD; Petroni G; Ward K; Zheng W; Mistro M; Libby B; McLaughlin C; Showalter TN; Janowski EM
Brachytherapy; 2024; 23(3):248-256. PubMed ID: 38519352
[TBL] [Abstract][Full Text] [Related]
113. Recent Advances and Adaptive Strategies in Image Guidance for Cervical Cancer Radiotherapy.
Anghel B; Serboiu C; Marinescu A; Taciuc IA; Bobirca F; Stanescu AD
Medicina (Kaunas); 2023 Sep; 59(10):. PubMed ID: 37893453
[TBL] [Abstract][Full Text] [Related]
114. EviGUIDE - a tool for evidence-based decision making in image-guided adaptive brachytherapy for cervical cancer.
Ecker S; Kirisits C; Schmid M; Knoth J; Heilemann G; De Leeuw A; Sturdza A; Kirchheiner K; Jensen N; Nout R; Jürgenliemk-Schulz I; Pötter R; Spampinato S; Tanderup K; Eder-Nesvacil N
Radiother Oncol; 2023 Sep; 186():109748. PubMed ID: 37330055
[TBL] [Abstract][Full Text] [Related]
115. Dosimetric and clinical outcomes of CT based HR-CTV delineation for HDR intracavitary brachytherapy in carcinoma cervix - a retrospective study.
Bandyopadhyay A; Ghosh AK; Chhatui B; Das D
Rep Pract Oncol Radiother; 2021; 26(2):170-178. PubMed ID: 34211766
[TBL] [Abstract][Full Text] [Related]
116. Clinical outcome after high dose rate intracavitary brachytherapy with traditional point 'A' dose prescription in locally advanced carcinoma of uterine cervix: dosimetric analysis from the perspective of computed tomography imaging-based 3-dimensional treatment planning.
Dhabal S; Basu A; Sau S; Sau S; Maiti PK; Chakravarty A
Obstet Gynecol Sci; 2024 Jan; 67(1):67-75. PubMed ID: 37817413
[TBL] [Abstract][Full Text] [Related]
117. Predictive Factors for Toxicity After Primary Chemoradiation for Locally Advanced Cervical Cancer: A Systematic Review.
Corbeau A; Heemsbergen WD; Kuipers SC; Godart J; Creutzberg CL; Nout RA; de Boer SM
Int J Radiat Oncol Biol Phys; 2024 May; 119(1):127-142. PubMed ID: 37979708
[TBL] [Abstract][Full Text] [Related]
118. The effect of lower urinary tract substructure doses on side effects of cervical cancer image-guided adaptive brachytherapy.
Azak C; Kavak G; Ertan F; Alioğlu F; Akkaş EA; Göksel F; Karakaya E
J Cancer Res Ther; 2023 Oct; 19(7):1825-1830. PubMed ID: 38376285
[TBL] [Abstract][Full Text] [Related]
119. Clinical outcomes of adaptive intracavitary and interstitial brachytherapy technique in locally advanced cervical cancer: A real-world data.
Kashid SR; Gurram L; Pullan S; Chopra S; Mittal P; Ghadi Y; Dheera A; Scaria L; Kohle S; Kadam S; Ghosh J; Rath S; Gupta S; Mahantshetty U
Brachytherapy; 2024 Apr; ():. PubMed ID: 38641455
[TBL] [Abstract][Full Text] [Related]
120. IBS-GEC ESTRO-ABS recommendations for CT based contouring in image guided adaptive brachytherapy for cervical cancer.
Mahantshetty U; Poetter R; Beriwal S; Grover S; Lavanya G; Rai B; Petric P; Tanderup K; Carvalho H; Hegazy N; Mohamed S; Ohno T; Amornwichet N
Radiother Oncol; 2021 Jul; 160():273-284. PubMed ID: 34019918
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
